A
Adam Meijer
Researcher at Erasmus University Medical Center
Publications - 177
Citations - 11686
Adam Meijer is an academic researcher from Erasmus University Medical Center. The author has contributed to research in topics: Influenza A virus & Medicine. The author has an hindex of 34, co-authored 152 publications receiving 8656 citations. Previous affiliations of Adam Meijer include University of Vienna.
Papers
More filters
Journal ArticleDOI
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.
Victor M. Corman,Olfert Landt,Marco Kaiser,Richard Molenkamp,Adam Meijer,Daniel K.W. Chu,Tobias Bleicker,Sebastian Brünink,Julia Schneider,Marie Luisa Schmidt,Daphne G.J.C. Mulders,Bart L. Haagmans,Bas van der Veer,Sharon van den Brink,Lisa Wijsman,Gabriel Goderski,Jean Louis Romette,Joanna Ellis,Maria Zambon,Malik Peiris,Herman Goossens,Chantal B.E.M. Reusken,Marion Koopmans,Christian Drosten +23 more
TL;DR: A validated diagnostic workflow for 2019-nCoV is presented, its design relying on close genetic relatedness of 2019- nCoV with SARS coronavirus, making use of synthetic nucleic acid technology.
Journal ArticleDOI
Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.
Maarten O Blanken,Maroeska M. Rovers,Jorine M Molenaar,Pauline L Winkler-Seinstra,Adam Meijer,Jan L. L. Kimpen,Louis Bont +6 more
TL;DR: Findings implicate RSV infection as an important mechanism of recurrent wheeze during the first year of life in otherwise healthy preterm infants, even after the end of treatment.
Journal ArticleDOI
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.
Angie Lackenby,Olav Hungnes,Susanne Gjeruldsen Dudman,Adam Meijer,W J Paget,Alan J. Hay,Maria Zambon +6 more
TL;DR: Results from analysis of early winter A(H1N1) virus isolates has revealed that a significant proportion, approximately 14% of these European strains, are resistant to oseltamivir (Tamiflu), the most widely used anti-influenza drug, but retain sensitivity to zanamivIR (Relenza) and amantadine/rimanadine.
Journal ArticleDOI
Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands.
Bas B. Oude Munnink,David F. Nieuwenhuijse,Mart L. Stein,Áine O'Toole,Manon R. Haverkate,Madelief Mollers,Sandra K Kamga,Claudia M. E. Schapendonk,Mark Pronk,Pascal Lexmond,Anne van der Linden,Theo M. Bestebroer,Irina Chestakova,Ronald J. Overmars,Stefan van Nieuwkoop,Richard Molenkamp,Annemiek A. van der Eijk,Corine H. GeurtsvanKessel,Harry Vennema,Adam Meijer,Andrew Rambaut,Jaap T. van Dissel,Reina S. Sikkema,Aura Timen,Marion Koopmans +24 more
TL;DR: The combination of near to real-time whole-genome sequence analysis and epidemiology resulted in reliable assessments of the extent of SARS-CoV-2 transmission in the community, facilitating early decision-making to control local transmission of the virus in the Netherlands.
Journal ArticleDOI
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015
Adam Meijer,Helena Rebelo-de-Andrade,Helena Rebelo-de-Andrade,Vanessa Correia,Vanessa Correia,Terry G. Besselaar,Renu Drager-Dayal,Alicia M. Fry,V. Gregory,Larisa V. Gubareva,Tsutomu Kageyama,Angie Lackenby,Janice Lo,Takato Odagiri,Dmitriy Pereyaslov,Marilda M. Siqueira,Emi Takashita,Masato Tashiro,Dayan Wang,Sun Wong,Wenqing Zhang,Rod S. Daniels,Aeron C. Hurt +22 more
TL;DR: The overall frequency of viruses with RI or HRI by the NAIs was lower than that observed in 2013–14, but similar to the 2012–13 period (0.6%).